Network meta-analysis on the efficacy and safety of management for resectable stage IIIA-N2 non-small cell lung cancer
Abstract Background There is controversy regarding the optimal treatment for stage IIIA-N2 non-small cell lung cancer (NSCLC). We aimed to address this crucial issue through a frequentist network meta-analysis. Methods We conducted a literature database search for randomized controlled trials compar...
Saved in:
| Main Authors: | Qiduo Yu, Haoshuai Yang, Fei Xiao, Zihan Wang, Zhenrong Zhang, Qianli Ma, Hongxiang Feng, Zhoujunyi Tian, Jin Zhang, Chaoyang Liang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-024-13047-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer
by: Pin-Ching Hu, et al.
Published: (2024-11-01) -
Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-based retrospective cohort study
by: Diyang Zhu, et al.
Published: (2025-02-01) -
Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it
by: Shu-Xian Zhang, et al.
Published: (2025-01-01) -
Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer
by: Ruiqiang Song, et al.
Published: (2025-07-01) -
Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke Arteriosclerosis y nuevas perspectivas de los inhibidores del receptor GPIIb/IIIa en stroke
by: GUSTAVO SAPOSNIK, et al.
Published: (2000-03-01)